Member Info for doggo

Into a very good week in FFWD history

Shareholders of the Company holding approximately 56% of the outstanding shares of the Company have agreed to vote in favour of the Transaction and related matters, and shareholders of Yooma holding approximately 76% of the outstanding shares of Yooma have agreed to vote in favour of the Transaction.

Board Recommendation

After careful consideration, the board of directors of the Company unanimously determined, after consultation with its legal advisors, that the Transaction is in the best interests of the Company and unanimously recommends that its shareholders vote for the Transaction at the upcoming special shareholders meeting. The recommendation of the Company’s Board is based on various factors that will be described more fully in the Circular.

Globalive Technology Inc. (TSX-V: LIVE) (the “Company”), a technology company based in Toronto, Ontario, announced today that it has signed a binding arrangement agreement (the “Agreement”) with Yooma Corp. (“Yooma”) to complete its previously announced arm’s length reverse take-over of Yooma (the “Transaction”). The Transaction is to be completed by way of a court approved plan of arrangement under the Business Corporations Act (Ontario) with the common shares of the resulting issuer (the “Resulting Issuer”) continuing following the amalgamation of the Company and Yooma to be listed on the Canadian Securities Exchange (the “CSE”). The CSE has conditional approved the listing of the Resulting Issuer shares on completion of the Transaction subject to customary conditions.

So what advantages does Emmac have over ALL the big Canadian companies.

1. Production costs are huge % lower than ANY competitor
2. Carbon footprint far lower (you’ll realise the significance soon)
3. Cultural advantage
4. Seed to sale DNA tracking from plant to consumer

Big big move https://www.bloomberg.com/news/articles/2020-12-16/aphria-tilray-announce-deal-to-create-biggest-cannabis-company

Aurora sat on 450 million, Aphria sat on 350 million and of course the giant canopy Growth with a cool 1.5 billon cash on hand

Bounce off like clockwork

Clear sky costs more than 7p.
Intraday we hit a triple bottom. Now is the time to be holding.

That’s an excellent RNS. Sellers regret coming.

FFWD needs to move 25% to reach placing price and 40% to reach NAV ~

A lot of the raise went to large shareholders & their friends/family. I’m confident they bought with the prospect of the SP in the near future being far more than current NAV.

Today’s interview cements Emmac as being superbly well placed to be a multi -billon £ player in 2021.
Add the monster 43.4% value in the Leap IPO, then add the best 2 near term plays in the PF Portage & Juvenescence and this could be a very significant rerate in a short time frame.

Or ODONNELL Is correct. Who knows..

Watch it you might decide to buy sell or hold afterwards.

He’s pointed out why we’ve raised & held the £2 million.

The changes to the landscape brought on by EU regulations changing, FCA rules changing etc

Expect news shortly

Exported 2 tonnes to Israel, now supplying multiple CBD products to Boots

What would that do to the SP?

Selling at 6.6p would possibly be seen as a schoolboy error.

Superb watch.

Triple bottom in play. Will see bullish reversal above previous resistance. Watch

I called out the ODonnell clan months ago. It’s a minimum of 4 separate people logging in and using their account.
We have the lunatic who types in UPPER CASE because they can’t see, the lunatic who updates us on their medical issues, the lunatic who asks if trade X is a buy/sell, the lunatic who tells us about market mechanics and how it works, the lunatic who will post huge monologues to interrupt the board flow.
Stop answering them and ignore their games or block them. They thrive on interaction.

Was up to the end of September.

What significant things have occurred since..

This is a ground-breaking moment for the UK medical cannabis industry. EMMAC's complete control of our supply chain, from cultivation and extraction to manufacture and distribution, allows us to offer a consistent, reliable and high-quality product in the UK at a price point that has hitherto not been possible. Since our inception, EMMAC has sought to address the challenges faced by patients and clinicians in the UK, including availability of product and accessibility of price, as identified in the 2019 NHS England report: Barriers to accessing cannabis-based products for medicinal use on NHS prescription. As always, we remain committed to working closely with the public and private healthcare sectors to help solve these barriers to access of cannabis-based medicines."

I would read and reread the above. Draw your own conclusions.

The Emmac SPAC reversal was pulled. I don’t think it was ever going to happen, but it has provided an internal valuation for Emmac that can form the basis of their London IPO.

Leap intention to IPO announced after the end of September. This will be worth a multiple of current MCAP.

Portage has increased from $9 to $14 and will continue to increase in the lead up to Nasdaq uplist. Expect to see $30 hit pre uplist.

Juvenescence continue their Series C raise. Note the Swiss merchant banks involved.

Stop your wailing and either hold or sell at ~40% discount to Septembers NAV of 9.45p.

with casino games and virtuals the operator pays a certain percentage of revenue back to the provider.

Quote a CEO of a Leap customer

SportNation & Red Zone Nasdaq was owned.
The golf has gone live as well last week